Leap Investments’s Abiomed Inc ABMD Stock Holding History

Leap Investments’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,300	Closed	-$222K	–	632
2019 Q4	$222K	Buy	+1,300	New	+$241K	0.1%	306

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Leap Investments's ABMD Position: Q1 2020 in Review

Leap Investments sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 1,300 shares — an estimated $222K sold.

Leap Investments first reported a position in ABMD in Q4 2019 and held it in 1 quarter. The position peaked at $222K in Q4 2019. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

Leap Investments reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
Leap Investments sold 1,300 Abiomed Inc shares in Q1 2020, an estimated $222K.
Leap Investments first reported a position in Abiomed Inc in Q4 2019 and held it in 1 quarter.
Leap Investments's Abiomed Inc position peaked at $222K in Q4 2019.
412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Leap Investments's 13F filing for Q1 2020, filed 15 May 2020.